111's long-term debt is $3.8M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest long-term debt for YI is $3.8M as of March 2026. That compares with $47M in the prior-year period — down 91.8% year over year. Investors often review this figure alongside 111's historical trend and sector peers before judging valuation or financial health.
Over the past year, YI's long-term debt moved from $47M to $3.8M — a 91.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 111's operating scale or balance-sheet position.
A long-term debt figure of $3.8M for YI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting YI's long-term debt ($3.8M), review year-over-year change from $47M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack 111's long-term debt against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.